Molecules to Medicine
A Clinical Trial and Suicide Leave Many Questions: Part 2: Investigator Responsibilities
December 13th, 2012 |
1
There are many disturbing things that happened during the clinical trial on which Dan Markingson committed suicide. Besides the issue of consent, or lack thereof, which I raised in my last post, one of the most disturbing aspects to me has been the lack of accountability and the apparent violations of clinical practice standards, with [...]
Keep reading »
See what we're tweeting about
